Regulatory T Cells in the Tumor Microenvironment.

CD25 CD39 CTLA4 Cancer immunotherapy Clinical trials Foxp3 IL-10 IL-2 IL-35 LAG3 NRP1 Regulatory T cells (Treg) Tolerance Tumor immunology Tumor microenvironment (TME)

Journal

Advances in experimental medicine and biology
ISSN: 0065-2598
Titre abrégé: Adv Exp Med Biol
Pays: United States
ID NLM: 0121103

Informations de publication

Date de publication:
2020
Historique:
entrez: 29 10 2020
pubmed: 30 10 2020
medline: 14 1 2021
Statut: ppublish

Résumé

Regulatory T cells (T

Identifiants

pubmed: 33119878
doi: 10.1007/978-3-030-49270-0_6
doi:

Substances chimiques

FOXP3 protein, human 0
Forkhead Transcription Factors 0
IL2RA protein, human 0
Interleukin-2 Receptor alpha Subunit 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

105-134

Auteurs

Rebekah E Dadey (RE)

Department of Immunology, University of Pittsburgh School of Medicine, Pittsburgh, PA, USA.
Tumor Microenvironment Center, University of Pittsburgh Medical Center (UPMC) Hillman Cancer Center, Pittsburgh, PA, USA.
Cancer Immunology and Immunotherapy Program, UPMC Hillman Cancer Center, Pittsburgh, PA, USA.
Graduate Program of Microbiology and Immunology, University of Pittsburgh School of Medicine, Pittsburgh, PA, USA.

Creg J Workman (CJ)

Department of Immunology, University of Pittsburgh School of Medicine, Pittsburgh, PA, USA.
Tumor Microenvironment Center, University of Pittsburgh Medical Center (UPMC) Hillman Cancer Center, Pittsburgh, PA, USA.
Cancer Immunology and Immunotherapy Program, UPMC Hillman Cancer Center, Pittsburgh, PA, USA.

Dario A A Vignali (DAA)

Department of Immunology, University of Pittsburgh School of Medicine, Pittsburgh, PA, USA. dvignali@pitt.edu.
Tumor Microenvironment Center, University of Pittsburgh Medical Center (UPMC) Hillman Cancer Center, Pittsburgh, PA, USA. dvignali@pitt.edu.
Cancer Immunology and Immunotherapy Program, UPMC Hillman Cancer Center, Pittsburgh, PA, USA. dvignali@pitt.edu.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH